U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H17N3O4S
Molecular Weight 311.357
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of METAMIZOLE

SMILES

CN(CS(O)(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2

InChI

InChIKey=LVWZTYCIRDMTEY-UHFFFAOYSA-N
InChI=1S/C13H17N3O4S/c1-10-12(14(2)9-21(18,19)20)13(17)16(15(10)3)11-7-5-4-6-8-11/h4-8H,9H2,1-3H3,(H,18,19,20)

HIDE SMILES / InChI

Molecular Formula C13H17N3O4S
Molecular Weight 311.357
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Dipyrone, also known as Metamizole (INN), is an ampyrone sulfonate analgesic, antispasmodic and antipyretic. It was withdrawn from US market in 1977 on the basis of reports of agranulocytosis. Depyrone is still used to treat severe and diffucult for relieving pains of different origin; headache, tooth-ache, pains in the joints, muscles, following traumas and operations, gall and kidney colics, neurites, neuralgias, traumatic cerebrasthenia; inflammation of upper respiratory ways of microbial or virus origin; chorea; febrile states. Mechanism of action of dipyrone is complex. It is believed that dipyrone exerts its action by inhibiting COX-3, and activates opioid and cannabioid systems either itself, or by products of its metabolic degradation.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P23219|||Q5T7T7
Gene ID: 5742.0
Gene Symbol: PTGS1
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
NEURALGIN

Approved Use

Severe and diffucult for relieving pains of different origin; headache, tooth-ache, pains in the joints, muscles, following traumas and operations, gall and kidney colics, neurites, neuralgias, traumatic cerebrasthenia; inflammation of upper respiratory ways of microbial or virus origin; chorea; febrile states.
Primary
OPTALGIN

Approved Use

Optalgin Injection, by intramuscular administration, is indicated to lower temperature in life-threatening situations, when this cannot be achieved by other means. Hyperthermic patients in critical condition may also be treated in non-hospital environment, under close medical supervision.
PubMed

PubMed

TitleDatePubMed
Drug utilization and morbidity statistics for the evaluation of drug safety in Sweden.
1984
Modifying potential of thirty-one chemicals on the short-term development of gamma-glutamyl transpeptidase-positive foci in diethylnitrosamine-initiated rat liver.
1984 Oct
Mode of analgesic action of dipyrone: direct antagonism of inflammatory hyperalgesia.
1985 Aug 27
Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study.
1986 Oct 3
Diagnosis of antibody-mediated drug allergy. Pyrazolinone and pyrazolidinedione cross-reactivity relationships.
1987 Nov
[Effects of verapamil on behavioral and microcirculatory disorders in pain syndrome of spinal etiology].
1990 May
Octreotide dependency and headache: a case report.
1994 Aug
Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia.
1996 Jun
Use of dipyrone during pregnancy and risk of Wilms' tumor. Brazilian Wilms' Tumor Study Group.
1996 Sep
Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action.
1998 Mar 26
Doctor, there's a fly in my soup! Angiotensin-converting enzyme inhibitors, endogenous opioids and visual hallucinations.
2001 Dec
A comparative study of the antipyretic effects of indomethacin and dipyrone in rats.
2002 Jan
Antinociceptive profile of (-)-spectaline: a piperidine alkaloid from Cassia leptophylla.
2003 Sep
Cloning, expression, and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention.
2005 Dec
[Acute intermittent porphyria and oral contraception. Case report].
2006 Mar
Lack of effect of naltrindole on the spinal synergism of morphine and non-steroidal anti-inflammatory drugs (NSAIDS).
2009 Jun
Over-expression of the LTC4 synthase gene in mice reproduces human aspirin-induced asthma.
2011 Aug
Synergistic effect of the L-tryptophan and kynurenic acid with dipyrone or paracetamol in mice.
2013 Sep 25
Patents

Sample Use Guides

Dipyrone was administered orally, as subcutaneous and intramuscular injections (daily dose 0.25-1 g as 50% solution), or by intravenous injection.
Route of Administration: Other
Cyclooxygenase activity was measured by the formation of PGE2 after exposure to exogenous 30 μM acid for 10 min. Dipyrone inhibited COX-1 with IC50 350 uM, and COX-3 with IC50 of 52 uM.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:27:11 GMT 2023
Edited
by admin
on Fri Dec 15 16:27:11 GMT 2023
Record UNII
934T64RMNJ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
METAMIZOLE
WHO-DD  
Common Name English
Metamizole [WHO-DD]
Common Name English
METHAMIZOLE-
Common Name English
METHANESULFONIC ACID, (ANTIPYRINYLMETHYLAMINO)-
Common Name English
METHANESULFONIC ACID, ((2,3-DIHYDRO-1,5-DIMETHYL-3-OXO-2-PHENYL-1H-PYRAZOL-4-YL)METHYLAMINO)-
Common Name English
Dipyrone free acid anhydrous
Common Name English
METHANESULFONIC ACID, 1-((2,3-DIHYDRO-1,5-DIMETHYL-3-OXO-2-PHENYL-1H-PYRAZOL-4-YL)METHYLAMINO)-
Common Name English
Classification Tree Code System Code
WHO-ATC N02BB72
Created by admin on Fri Dec 15 16:27:12 GMT 2023 , Edited by admin on Fri Dec 15 16:27:12 GMT 2023
WHO-ATC N02BB52
Created by admin on Fri Dec 15 16:27:12 GMT 2023 , Edited by admin on Fri Dec 15 16:27:12 GMT 2023
Code System Code Type Description
EVMPD
SUB03187MIG
Created by admin on Fri Dec 15 16:27:12 GMT 2023 , Edited by admin on Fri Dec 15 16:27:12 GMT 2023
PRIMARY
DAILYMED
934T64RMNJ
Created by admin on Fri Dec 15 16:27:12 GMT 2023 , Edited by admin on Fri Dec 15 16:27:12 GMT 2023
PRIMARY
EPA CompTox
DTXSID6044143
Created by admin on Fri Dec 15 16:27:12 GMT 2023 , Edited by admin on Fri Dec 15 16:27:12 GMT 2023
PRIMARY
DRUG CENTRAL
4659
Created by admin on Fri Dec 15 16:27:12 GMT 2023 , Edited by admin on Fri Dec 15 16:27:12 GMT 2023
PRIMARY
DRUG BANK
DB04817
Created by admin on Fri Dec 15 16:27:12 GMT 2023 , Edited by admin on Fri Dec 15 16:27:12 GMT 2023
PRIMARY
FDA UNII
934T64RMNJ
Created by admin on Fri Dec 15 16:27:12 GMT 2023 , Edited by admin on Fri Dec 15 16:27:12 GMT 2023
PRIMARY
PUBCHEM
3111
Created by admin on Fri Dec 15 16:27:12 GMT 2023 , Edited by admin on Fri Dec 15 16:27:12 GMT 2023
PRIMARY
CAS
50567-35-6
Created by admin on Fri Dec 15 16:27:12 GMT 2023 , Edited by admin on Fri Dec 15 16:27:12 GMT 2023
PRIMARY
WIKIPEDIA
METAMIZOLE
Created by admin on Fri Dec 15 16:27:12 GMT 2023 , Edited by admin on Fri Dec 15 16:27:12 GMT 2023
PRIMARY
ECHA (EC/EINECS)
256-627-7
Created by admin on Fri Dec 15 16:27:12 GMT 2023 , Edited by admin on Fri Dec 15 16:27:12 GMT 2023
PRIMARY
SMS_ID
100000085923
Created by admin on Fri Dec 15 16:27:12 GMT 2023 , Edited by admin on Fri Dec 15 16:27:12 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
METABOLITE ACTIVE -> PRODRUG
Metamizole is rapidly hydrolyzed to 4-MMA in gastric juice and this is the predominat species absorbed.
MAJOR
PLASMA; URINE
METABOLITE ACTIVE -> PARENT